News
$1.8bn investment sees Lilly expand manufacturing footprint in Ireland
Eli Lilly and Company has announced a $1 billion expansion of its Limerick, Ireland, manufacturing site to increase production of biologic active ingredients, including...
FDA approves Roche’s Tecentriq Hybreza cancer immunotherapy
The U.S. Food and Drug Administration (FDA) has approved Roche's Tecentriq Hybreza (atezolizumab and hyaluronidase-tqjs), the first and only PD-(L)1 inhibitor for subcutaneous (SC),...
DOL Finder platform launch enables users to identify and monitor most influential digital healthcare...
A UK and US based digital insights consultancy has launched a new platform, DOL Finder, that enables users to identify the most influential healthcare...
